TransEnterix, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TRXDW research report →
Price Chart
About the company
Asensus Surgical, Inc. is a medical technology firm dedicated to the innovation, development, and commercialization of robotic surgical systems aimed at enhancing minimally invasive procedures. The company’s global reach extends across the United States, Europe, the Middle East, Africa, and Asia.
- CEO
- Anthony Fernando
- Employees
- 207
- HQ
- US
Get TickerSpark's AI analysis on TRXDW
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $40.09M
- P/E
- -0.48
- PEG
- -0.08
- P/S
- 4.67
- P/B
- 1.12
- EV/EBITDA
- -0.39
- Div Yield
- 0.00%
- Gross Margin
- -58.66%
- Op Margin
- -910.92%
- Net Margin
- -914.46%
- ROE
- -117.89%
- ROIC
- -159.64%
Latest fiscal year · YoY change
- Revenue
- $8.58M+21.0%
- Gross Profit
- $-5,031,000-32.9%
- Op Income
- $-78,130,000
- Net Income
- $-78,433,000-3.8%
- EPS
- $-0.31+3.1%
- OCF Growth
- -8.0%
- FCF Growth
- -6.6%
- 52W High
- $0.15
- 52W Low
- $0.15
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 1.41
- RSI (14)
- 43
- Avg Volume
- 0
No earnings-call transcripts are available for TRXDW yet.
- Free Float
- 94.0%
- Shares Outstanding
- 267.28M
- Float Shares
- 251.37M
Our TRXDW coverage
Recent articles, reports, and earnings notes.
No research on TRXDW yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate TRXDW report →Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.